Company Profile

Cadence Biomedical Inc (AKA: Empowering Engineering Technologies Corporation~EETech)
Profile last edited on: 3/31/17      CAGE: 4W0G8      UEI:

Business Identifier: Improved mobility for people with disabilities.
Year Founded
2007
First Award
2011
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7511 Greenwood Avenue North Unit 104
Seattle, WA 98103
   (206) 659-0614
   info@cadencebio.com
   www.cadencebiomedical.com
Location: Single
Congr. District: 07
County: King

Public Profile

Formerly known as Empowering Engineering Technologies, Inc., Cadence Biomedical, Inc is an early stage medical device company committed to helping the 2.3 million Americans suffering from severe mobility impairments to gain a more mobile and independent life. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. The firm manufactures and distributes ExoWalk, an elastic tendon-like medical device that helps people with gait disabilities walk.. In 2012 firm introduced Kickstart™, a simple and intuitive custom fit orthosis designed to enhance stability and provide energy return during walking without the use of powered mechanisms. Kickstart is the first user-powered Kinetic Orthosis that allows users to initiate and swing through each step with more ease and confidence

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 1 NIH $330,747
Project Title: An Exotendon Prosthesis to Improve Walking for Lower Limb Amputees

Key People / Management

  Brian Glaister -- President and CoO

  Barry Hix -- CEO

  Jason Schoen -- Co-Founder and VP Product Development